DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 2Dr. Reddy's Laboratories
02 2ANI Pharmaceuticals Inc
03 6Accord healthcare
04 2Actavis Inc
05 2Alembic Pharmaceuticals Limited
06 2Alkem Laboratories
07 2Alter Laboratories Sa
08 2Amneal Pharmaceuticals
09 2Aristo Pharma GmbH
10 2Ascent Innovative Medicines
11 2Aurobindo Pharma Limited
12 2Aurovitas Spain, Sau
13 2Chartwell Pharmaceuticals llc
14 2Cinfa
15 4Farm Agon
16 3GL Pharma
17 2Hetero Drugs
18 2Intas Pharmaceuticals
19 4Intas Third Party Sales 2005 Sl
20 4LABORATORIOS NORMON SA
21 2Laboratorios Liconsa
22 4ORIFARM GROUP AS
23 2Orchid Pharma
24 22Pfizer Inc
25 1Precise Group
26 2STADA Arzneimittel
27 4Sandoz B2B
28 2Sun Pharmaceutical Industries Limited
29 2Teva Pharmaceutical Industries
30 2Unichem Laboratories Limited
31 4Zentiva
32 2Zydus Pharmaceuticals
Reset all filters
01 28Depot tablet
02 2ER TABLET
03 4ER Tablet
04 28Extended-Release Tablet
05 3Prolonged Release Tablet
06 2SR Tablet
07 4TABLET (EXTENDED-RELEASE)
08 28TABLET, EXTENDED RELEASE;ORAL
09 1Tablet
Reset all filters
01 25Authorized
02 3Cancelled
03 8DISCN
04 3Dossier Availability- Q2 2018
05 3Generic
06 2Generic EU CTD
07 4Prescription
08 16RX
09 36Blank
Reset all filters
01 2About Fesoterodine
02 26FESOTERODINE FUMARATE
03 2Fesoterodina Alter
04 2Fesoterodina Aristo
05 2Fesoterodina Aurovitas
06 2Fesoterodina Cinfa
07 2Fesoterodina Liconsa
08 2Fesoterodina Normogen
09 2Fesoterodina Normon
10 2Fesoterodina Stada
11 2Fesoterodina Teva
12 4Fesoterodine Accord
13 2Fesoterodine Intas
14 4Fesoterodine Zentiva
15 2SANDOZ FESOTERODINE FUMARATE
16 4TOVIAZ
17 26Toviaz
18 12Blank
Reset all filters
01 3Austria
02 4Canada
03 9India
04 28Norway
05 28Spain
06 28USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2019-08-13
Application Number : 204975
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2019-08-13
Application Number : 204975
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204868
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204868
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204973
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204973
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2015-12-10
Application Number : 204827
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2015-12-10
Application Number : 204827
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204504
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204504
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-01-05
Application Number : 204983
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-01-05
Application Number : 204983
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2024-01-09
Application Number : 204792
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2024-01-09
Application Number : 204792
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TOVIAZ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2008-10-31
Application Number : 22030
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TOVIAZ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2008-10-31
Application Number : 22030
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 204844
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date :
Application Number : 204844
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2017-10-03
Application Number : 204946
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2017-10-03
Application Number : 204946
Regulatory Info : RX
Registration Country : USA